In addition, ER-positive/PR-negative breast cancer patients tend to be older and manifest a more aggressive behavior, with larger tumor size, lymph node positivity, higher histological grade, and shortened breast cancer-specific survival (BCSS). This evidence concerns the gene ESR1 and breast carcinoma.